Page last updated: 2024-11-06

4-methoxy-1-naphthalaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methoxy-1-naphthalaldehyde: used for fluorometric assays for isozymes of human alcohol dehydrogenase; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID85217
CHEMBL ID4447838
SCHEMBL ID545661
MeSH IDM0166426

Synonyms (37)

Synonym
AC-7718
4-methoxy-1-naphthaldehyde
1-naphthalenecarboxaldehyde, 4-methoxy-
nsc97025
15971-29-6
nsc-97025
inchi=1/c12h10o2/c1-14-12-7-6-9(8-13)10-4-2-3-5-11(10)12/h2-8h,1h
4-methoxy-1-naphthaldehyde, 99%
STK376805
4-methoxynaphthalene-1-carbaldehyde
AKOS000113157
M1049
unii-e2l48ul293
e2l48ul293 ,
4-methoxy-1-naphthalenecarboxaldehyde
einecs 240-109-2
nsc 97025
4-methoxy-1-naphthalaldehyde
FT-0618870
AM20030075
SCHEMBL545661
1-naphthaldehyde, 4-methoxy-
DTXSID60166717
CHEMBL4447838
J-009634
CS-W016898
SY040606
DS-15375
mfcd00004006
calciumcyanamide
4-methoxynaphthalene-1-carboxaldehyde
Q63409783
AC8026
4-methoxy-naphthalene-1-carbaldehyde
EN300-32026
4-methoxy-1-naphthylaldehyde
Z337707762
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1602658Inhibition of mouse GAT-1 assessed as percentage of remaining specific binding of NO711 at 1 uM after 4 hrs by LC-ESI-MS/ms analysis relative to control2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.85 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]